Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

Daniel Kopasker; Clare Robertson; Lorna Aucott; Thenmalar Vadiveloo; Mari Imamura; Paul Manson; Andrew Walker; Gordon Urquhart; Miriam Brazzelli; Graham Scotland; Aberdeen HTA Group

Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

Daniel Kopasker, Clare Robertson, Lorna Aucott, Thenmalar Vadiveloo, Mari Imamura, Paul Manson, Andrew Walker, Gordon Urquhart, Miriam Brazzelli, Graham Scotland^*, Aberdeen HTA Group

^*Corresponding author for this work

Research output: Book/Report › Commissioned Report

Abstract

Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

Original language	English
Publisher	National Institute for Health and Care Excellence (NICE)
Publication status	Published - 2020

Bibliographical note

This report was commissioned by the NIHR Systematic Reviews Programme as project number 130569.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@book{3f6339ae619946a2991971e41557b337,

title = "Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer",

abstract = "Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence",

author = "Daniel Kopasker and Clare Robertson and Lorna Aucott and Thenmalar Vadiveloo and Mari Imamura and Paul Manson and Andrew Walker and Gordon Urquhart and Miriam Brazzelli and Graham Scotland and {Aberdeen HTA Group}",

note = "This report was commissioned by the NIHR Systematic Reviews Programme as project number 130569.",

year = "2020",

language = "English",

publisher = "National Institute for Health and Care Excellence (NICE)",

}

TY - BOOK

T1 - Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

AU - Kopasker, Daniel

AU - Robertson, Clare

AU - Aucott, Lorna

AU - Vadiveloo, Thenmalar

AU - Imamura, Mari

AU - Manson, Paul

AU - Walker, Andrew

AU - Urquhart, Gordon

AU - Brazzelli, Miriam

AU - Scotland, Graham

AU - Aberdeen HTA Group

N1 - This report was commissioned by the NIHR Systematic Reviews Programme as project number 130569.

PY - 2020

Y1 - 2020

N2 - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

AB - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

M3 - Commissioned Report

BT - Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

PB - National Institute for Health and Care Excellence (NICE)

ER -

Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer

Abstract

Bibliographical note

UN SDGs

Fingerprint

Cite this